FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210177840> ?p ?o ?g. }

• W3210177840 endingPage "11688" @default.
• W3210177840 startingPage "11688" @default.
• W3210177840 abstract "Human Ezrin Peptides (HEPs) are inhibitors of expression of IL-6 and other inflammatory cytokines, amplifiers of adaptive B cell and T cell immunity and enhancers of tissue repair. The mutation stable C-terminus of HIV gp120, mimics 69% of the “Hep-receptor”, a zipped α-helical structure in the middle of the α domain of human ezrin protein. Synthetic peptides homologous to the Hep-receptor of ezrin of five to fourteen amino acids, activate anti-viral immunity against a wide range of viruses (HIV, HCV, herpes, HPV, influenza and other human respiratory viruses). Human Ezrin Peptide One (HEP1) TEKKRRETVEREKE (brand name Gepon, registered for human use in Russia from 2001) is a successful treatment for opportunistic infections in HIV-infected patients. That treats HEP1and prevents mucosal candidiasis, herpes zoster outbreaks and infection-induced chronic diarrhea. There are clinical publications in Russian on the successful treatments of chronic recurrent vaginal candidiasis, acute and chronic enterocolitis and dysbacteriosis, which are accompanied by normalization of the mucosal microbiome, and the decline or disappearance of inflammation. HEP1 is also an effective treatment and prevention for recurrent inflammation and ulceration in the stomach, duodenum and colon. HEP1 and RepG3 GEKKRRETVEREGG (a derivative of HEP1) have been used successfully as an inhaled spray peptide solution to treat a small number of human volunteers with mild-to-moderate COVID, resulting from SARS-CoV-2 infection, based on earlier successes in treating acute viral respiratory disease with inflammatory complications. Ezrin peptides seem to correct a dysregulation of innate immune responses to SARS-CoV-2. They are also adjuvants of B cell adaptive immunity and increase antibody titres, resulting in protection from lethal virus infection of mice. In a clinical study in Moscow, orally administered HEP1 was shown to enhance antibody-titres produced in response to hepatitis-B vaccination. These very preliminary but promising results with ezrin peptide treatment of COVID must be replicated in large-scale randomised placebo controlled clinical studies, to be verified." @default.
• W3210177840 created "2021-11-08" @default.
• W3210177840 creator A5031114079 @default.
• W3210177840 creator A5090991116 @default.
• W3210177840 date "2021-10-28" @default.
• W3210177840 modified "2023-10-02" @default.
• W3210177840 title "Ezrin Peptide Therapy from HIV to COVID: Inhibition of Inflammation and Amplification of Adaptive Anti-Viral Immunity" @default.
• W3210177840 cites W1577872659 @default.
• W3210177840 cites W176140375 @default.
• W3210177840 cites W1999616755 @default.
• W3210177840 cites W2037130111 @default.
• W3210177840 cites W2062892825 @default.
• W3210177840 cites W2111451681 @default.
• W3210177840 cites W2129129953 @default.
• W3210177840 cites W2136088887 @default.
• W3210177840 cites W2160466201 @default.
• W3210177840 cites W2162560056 @default.
• W3210177840 cites W2401981391 @default.
• W3210177840 cites W2410303529 @default.
• W3210177840 cites W2411907551 @default.
• W3210177840 cites W2416501623 @default.
• W3210177840 cites W2724873671 @default.
• W3210177840 cites W2910414574 @default.
• W3210177840 cites W2968244059 @default.
• W3210177840 cites W3007678277 @default.
• W3210177840 cites W3019785070 @default.
• W3210177840 cites W3039991939 @default.
• W3210177840 cites W3048885045 @default.
• W3210177840 cites W3090351609 @default.
• W3210177840 cites W3113121737 @default.
• W3210177840 cites W3119858919 @default.
• W3210177840 cites W3120542280 @default.
• W3210177840 cites W3129717864 @default.
• W3210177840 cites W3131820551 @default.
• W3210177840 cites W3133989519 @default.
• W3210177840 cites W3154092881 @default.
• W3210177840 cites W3161424923 @default.
• W3210177840 cites W3182840995 @default.
• W3210177840 cites W4211166592 @default.
• W3210177840 doi "https://doi.org/10.3390/ijms222111688" @default.
• W3210177840 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8584018" @default.
• W3210177840 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34769119" @default.
• W3210177840 hasPublicationYear "2021" @default.
• W3210177840 type Work @default.
• W3210177840 sameAs 3210177840 @default.
• W3210177840 citedByCount "7" @default.
• W3210177840 countsByYear W32101778402022 @default.
• W3210177840 countsByYear W32101778402023 @default.
• W3210177840 crossrefType "journal-article" @default.
• W3210177840 hasAuthorship W3210177840A5031114079 @default.
• W3210177840 hasAuthorship W3210177840A5090991116 @default.
• W3210177840 hasBestOaLocation W32101778401 @default.
• W3210177840 hasConcept C159047783 @default.
• W3210177840 hasConcept C193419808 @default.
• W3210177840 hasConcept C203014093 @default.
• W3210177840 hasConcept C2776914184 @default.
• W3210177840 hasConcept C2779341262 @default.
• W3210177840 hasConcept C71924100 @default.
• W3210177840 hasConcept C86803240 @default.
• W3210177840 hasConcept C8891405 @default.
• W3210177840 hasConceptScore W3210177840C159047783 @default.
• W3210177840 hasConceptScore W3210177840C193419808 @default.
• W3210177840 hasConceptScore W3210177840C203014093 @default.
• W3210177840 hasConceptScore W3210177840C2776914184 @default.
• W3210177840 hasConceptScore W3210177840C2779341262 @default.
• W3210177840 hasConceptScore W3210177840C71924100 @default.
• W3210177840 hasConceptScore W3210177840C86803240 @default.
• W3210177840 hasConceptScore W3210177840C8891405 @default.
• W3210177840 hasIssue "21" @default.
• W3210177840 hasLocation W32101778401 @default.
• W3210177840 hasLocation W32101778402 @default.
• W3210177840 hasLocation W32101778403 @default.
• W3210177840 hasLocation W32101778404 @default.
• W3210177840 hasOpenAccess W3210177840 @default.
• W3210177840 hasPrimaryLocation W32101778401 @default.
• W3210177840 hasRelatedWork W1574628415 @default.
• W3210177840 hasRelatedWork W2047765480 @default.
• W3210177840 hasRelatedWork W2057948995 @default.
• W3210177840 hasRelatedWork W2562955285 @default.
• W3210177840 hasRelatedWork W2793303916 @default.
• W3210177840 hasRelatedWork W3017822181 @default.
• W3210177840 hasRelatedWork W3032210197 @default.
• W3210177840 hasRelatedWork W3215784512 @default.
• W3210177840 hasRelatedWork W4307359803 @default.
• W3210177840 hasRelatedWork W573847062 @default.
• W3210177840 hasVolume "22" @default.
• W3210177840 isParatext "false" @default.
• W3210177840 isRetracted "false" @default.
• W3210177840 magId "3210177840" @default.
• W3210177840 workType "article" @default.